谷歌浏览器插件
订阅小程序
在清言上使用

Expression of the Receptor Tyrosine Kinase AXL and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma Enrolled in the METEOR Trial.

Journal of Clinical Oncology(2024)

引用 0|浏览4
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要